Hospital size matters when it comes to intensive care units (ICUs) adopting even the most routine prevention policies for catheter-associated urinary tract infections (CAUTI), according to a new study from researchers at Columbia University School of Nursing, published this month in the American Journal of Infection Control.
The study found that large hospitals -- those with more than 500 beds --had a 1.5 higher average rate of CAUTI than hospitals with 500 beds or less. Since larger hospitals, particularly teaching hospitals treat patients who are often sicker, the finding that their ICUs have higher incidences of CAUTI, while still a cause of concern, was not unanticipated.
Â
What was puzzling, say the researchers, is that ICUs in larger hospitals those with the higher rates of CAUTI -- were less likely to have implemented a CAUTI prevention policy.
"What we find so baffling is that the very hospitals that have the highest rates of CAUTI are not following the CAUTI preventive guidelines in their intensive care units," says the study's lead author, Laurie J. Conway, RN, MS, CIC.
Â
CAUTIs are common and costly occurrences in US hospitals and have been the target of recent national quality initiatives directed at infections acquired in hospital settings. Over the past 30 years, panels of experts in infection control and hospital epidemiology have unanimously recommended taking precautions to minimizing unnecessary urinary catheter use. Among the recommendations are substituting condom catheters for in dwelling catheters, using bladder ultrasound scanners to identify or rule out urinary retention, and using automated reminders, stop orders, or nurse-driven protocols to ensure catheters are discontinued as soon as they are no longer needed.
The researchers conclude that recent federal regulations requiring public reporting of CAUTI rates may serve to refocus attention on CAUTI prevention in ICUs in the United States.
Â
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.